Table 8.
Surgical management of LAH based on recent publications
| Reference (year) | No of patients with LAH | IOPTH | Pathology (%) | Surgery (%) | p/rHPT (%) | Perm. HypoPT (%) | |||
|---|---|---|---|---|---|---|---|---|---|
| SA | DA | PH | BNE | Scan-directed | |||||
| Wade et al. [100] | 19 | Yes | 68 | 32 (MGD) | 53 | 47 | 100 | 0 | |
| Marti et al. [102] | 27 | Yes | 41 | 15 | 44 | 67 | 33 | 23 | 0 |
| Skandarajah et al. [101] | 15 | Yes | 27 | 0 | 73 | 80 | 20 | 0 | 7 |
| Järhult et al. [34] | 71 | N/A | 45 | 3 | 52 | 97 | 3 | 42 | 13 |
| Carchman et al. [99] | 16 | Yes | 75 | 12.5 | 12.5 | 50 | 50 | 0 | 0 |
LAH lithium-associated hyperparathyroidism, SA single adenoma, DA double adenoma, PH parathyroid hyperplasia, MGD multiglandular disease, BNE bilateral neck exploration, p/rHPT permanent/recurrent hyperparathyroidism, Perm.HypoPT permanent hypoparathyroidism